Liu L Y
Cancer Institute, Chinese Academy of Medical Sciences, Beijing.
Zhonghua Fu Chan Ke Za Zhi. 1990 Mar;25(2):77-9, 123.
Between 1981-1988, 23 patients with epithelial ovarian cancer underwent second-look laparotomy after initial surgery followed by multiple courses of chemotherapy. There was no evidence of tumor before operation. Six patients (26%) had gross tumor and 5 (22%) had microscopic tumor. One of 3 patients with stage I or II and 50% (10/20) of patients with stage III and recurrent disease had positive second-look. Two of 7 (29%) patients with no residual tumor after initial surgery and 9 of 16 (56%) with residual tumor had positive second-look. It showed that the results of second-look were correlated with stage and residual tumor left after initial surgery. Sixteen patients had CA125 serum immunoassay prior to second-look. CA125 level was in normal limits (less than or equal to 65 U/ml) in 12 patients. Positive second-look findings were observed in 7 patients (58%), of which 5 had microscopic tumors. The results indicate that the second-look laparotomy is probably the best way to evaluate residual tumor in the abdominal cavity.
1981年至1988年间,23例上皮性卵巢癌患者在初次手术后接受了二次剖腹探查术,并进行了多疗程化疗。术前未发现肿瘤迹象。6例(26%)有肉眼可见的肿瘤,5例(22%)有微小肿瘤。3例Ⅰ期或Ⅱ期患者中有1例,Ⅲ期及复发性疾病患者中有50%(10/20)二次探查结果为阳性。初次手术后无残留肿瘤的7例患者中有2例(29%),有残留肿瘤的16例患者中有9例(56%)二次探查结果为阳性。这表明二次探查的结果与分期及初次手术后残留肿瘤有关。16例患者在二次探查前进行了CA125血清免疫测定。12例患者的CA125水平在正常范围内(小于或等于65 U/ml)。7例患者(58%)二次探查结果为阳性,其中5例有微小肿瘤。结果表明,二次剖腹探查术可能是评估腹腔内残留肿瘤的最佳方法。